25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

inhibits the capacity of monocytes <strong>and</strong> macrophages to present antigen to T cells.<br />

This is realized <strong>by</strong> down-regulation of constitutive <strong>and</strong> IFN-g-induced cell surface levels<br />

of MHC class II, of co-stimulatory molecules like CD86 <strong>and</strong> of some adhesion<br />

molecules such as CD58 [47±49]. In addition, IL-10 inhibits the monocytic production<br />

of IL-12, an essential mediator for the development of specific cellular immune defense<br />

[50]. On the other h<strong>and</strong>, IL-10 favors the phagocytic activity of monocytes <strong>and</strong><br />

macrophages [51]. This is realized among others <strong>by</strong> up-regulated expression of specific<br />

receptors that mediate the uptake of opsonized <strong>and</strong> non-opsonized microorganisms.<br />

In fact, IL-10-treated monocytes <strong>and</strong> macrophages show an enhanced expression<br />

not only of IgG Fc receptors (CD16, CD32 <strong>and</strong> CD64) but also of scavenger receptors<br />

like CD163 <strong>and</strong> CD14 [52±55]. Interestingly, IL-10 simultaneously diminishes<br />

the killing of ingested microorganisms [56]. The up-regulated expression of scavenger<br />

receptors is probably responsible for the observation that IL-10-treated monocytes<br />

<strong>and</strong> macrophages strongly ingest apoptotic cells (W.-D. Dæcke <strong>and</strong> R. Sabat, unpublished).<br />

The chemotaxis of monocytes is only weakly impaired <strong>by</strong> IL-10 [57].<br />

8.3.2<br />

Effectson T Cells<br />

8.3 Biological Activities of IL-10<br />

As well as the dominating indirect impact via APCs, IL-10 also exerts a direct effect<br />

on T cells (Fig. 8.1). In particular, inhibitory effects have been described on CD4 + T<br />

cells. IL-10 inhibits the proliferation as well as the cytokine synthesis of these cells.<br />

Concerning the latter, it affects their IL-2 <strong>and</strong> IFN-g as well as their IL-4 <strong>and</strong> IL-5 production<br />

as induced <strong>by</strong> various stimuli [58, 59]. At least in the human system, IL-10<br />

therefore seems to inhibit both the Th1- <strong>and</strong> Th2-type responses, though the effect on<br />

Th1 cells appears to be stronger [60]. The influence of IL-10 on CD4 + T cells is particularly<br />

marked on the naive cells. Activated <strong>and</strong> memory T cells seem to be rather in-<br />

Fig. 8.1 Effects of IL-10 on APC±T cell interaction. IL-10 suppresses the<br />

expression of pro-inflammatorycytokines <strong>and</strong> enhances the formation of<br />

anti-inflammatorymediators. Moreover, IL-10 inhibits the capacityof<br />

monocytes <strong>and</strong> macrophages to present antigen to T cells. (see color<br />

plates page XXV)<br />

159

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!